Tracking your GLP‑1 experience helps improve medication adherence, reduce side effects, and understand long-term progress. Learn how data-driven habits can support better outcomes and how Shotsy makes it simple.
Read More →Nausea is the most common GLP‑1 side effect, but it is also the most manageable. Learn when it peaks, why it happens, and the evidence-based strategies that reduce it.
Read More →Hair thinning on semaglutide or tirzepatide is usually temporary and driven by rapid weight loss, not the drug itself. Learn what the research shows and how to reduce shedding.
Read More →GLP‑1 medication prices range from $178 to $1,350 per month depending on your coverage. Learn what each medication costs, what insurance typically covers, and how the new Medicare GLP‑1 Bridge changes the picture.
Read More →Two oral GLP‑1 medications are now FDA-approved for weight loss. Learn how the Wegovy pill and Foundayo compare on effectiveness, dosing, side effects, and daily routine.
Read More →Up to 40 percent of weight lost on semaglutide or tirzepatide can be lean mass. Here is the evidence-based protocol to protect your muscle while losing fat.
Read More →There is no formal ban on drinking while taking semaglutide or tirzepatide, but alcohol interacts with these medications in ways that matter. Here is what the evidence says.
Read More →Weight loss plateaus on semaglutide or tirzepatide are normal and expected. Learn why they happen, when to worry, and five evidence-based steps to get moving again.
Read More →GLP‑1 medications suppress appetite by 30 to 50 percent on average, but individual responses vary significantly. Here is why some people still feel hungry, why others lose their appetite almost entirely, and what to do about both.
Read More →GLP‑1 medications mimic a natural gut hormone that stimulates insulin, slows gastric emptying, and reduces appetite through brain signaling. Here is how they work, why they last so much longer than the natural hormone, and where the science is heading.
Read More →The SURMOUNT-OSA trial showed tirzepatide reduced sleep apnea severity by roughly 50 to 60 percent at 52 weeks, with some patients able to discontinue CPAP. Here is what the research says and what to expect.
Read More →Bloating on GLP‑1 medications like semaglutide and tirzepatide is caused by delayed gastric emptying and reduced gut motility. Here is why it happens, what makes it worse, and what actually provides relief.
Read More →GLP‑1 medications increase your risk of dehydration because you eat less food, experience GI side effects, and may not feel as thirsty. Here is how much water you actually need and how to stay on top of it.
Read More →Some GLP‑1 users report mood changes and anxiety, while others feel better than ever. Here's what the research says about GLP‑1 medications and mental health, including what regulators found and when to talk to your doctor.
Read More →GLP‑1 medications do more than help with weight loss. Landmark trials show semaglutide reduces major cardiovascular events by 20%, earning Wegovy an FDA approval for heart risk reduction. Here's what the research says.
Read More →Nervous about your first GLP‑1 injection? All injectable GLP‑1 medications use pre-filled auto-injector pens that make the process simple. Here's a complete step-by-step guide to injecting safely and comfortably.
Read More →
